JW LIFESCIENCE CORPORATION
Founded in 1994, JW Life Science is an IV fluid specialist producing basic fluids, TPN, and specialty fluids, with a license-out agreement with Baxter.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1994 and listed on KOSPI in 2016, JW Life Science is a pharmaceutical company specializing in intravenous fluids. Its product lineup includes basic IV fluids, total parenteral nutrition (TPN), specialty fluids, and HEMO products; it has developed proprietary Non-PVC materials and signed an exclusive license-out and export agreement with Baxter of the US. In its 32nd fiscal year, separate-entity revenue was about KRW 234 billion, with affiliate JW Pharmaceutical accounting for over 75.9% of sales, and its TPN production facility has obtained EU-GMP certification.
Products & technology
- Basic IV FluidsBasic intravenous fluid products
- TPN (Total Parenteral Nutrition)High value-added total parenteral nutrition product using proprietary Non-PVC materials
- Specialty IV FluidsSpecialty intravenous fluid products
- HEMOIV fluid product line
Regulatory approvals
data.go.kr46 Korean MFDS drug approvals · 1977–2026
- MFDS drugPlajudex injection2026-05-29Drug · Prescription · Approval202601573
- MFDS drugPowerargine Inj. (L-arginine hydrochloride)2024-12-16Drug · Prescription · Approval202402962
- MFDS drugWINUF A PLUS Peri inj.2023-08-31Drug · Prescription · Approval202302603
- MFDS drugWINUF A PLUS Inj.2023-06-28Drug · Prescription · Approval202301977
- MFDS drugPreburofen Injection (Ibuprofen)2022-04-28Drug · Prescription · Approval202201730
- MFDS drugFluenpera Inj.2021-07-28Drug · Prescription · Approval202105581
- MFDS drugJsedex Inj.2020-11-12Drug · Prescription · Approval202007831
- MFDS drugLipision A Inj.2020-10-21Drug · Prescription · Approval202007209
- MFDS drugFinamoa Tab. 1mg2019-08-23Drug · Prescription · Approval201905988
- MFDS drugDutamoa Tab. 0.5mg2019-08-22Drug · Prescription · Approval201905934
- MFDS drugAcetaphen Inj.2019-05-10Drug · Prescription · Approval201903045
- MFDS drugCleancle (Irrigation Sol.)2017-06-09Drug · OTC · Notification201703175
Show 34 more
- MFDS drugLevetiram Inj. 1000mg2017-01-10Drug · Prescription · Approval201700234
- MFDS drugLevetiram Inj. 500mg2016-08-31Drug · Prescription · Approval201605338
- MFDS drugMomederm Cream2014-11-21Drug · Prescription · Notification201405441
- MFDS drugPregaton Tab.2014-10-14Drug · Prescription · Approval201404705
- MFDS drugJW Linezolid Inj.Revoked2014-09-15Drug · Prescription · Approval201404222
- MFDS drugJW 5% Dextrose Inj.2014-02-26Drug · Prescription · Notification201400872
- MFDS drugJW Moxifloxacin Inj. 400mg2013-10-22Drug · Prescription · Approval201309860
- MFDS drugWinuf Inj.2013-09-30Drug · Prescription · Approval201309522
- MFDS drugWinuf Peri Inj.2013-09-30Drug · Prescription · Approval201309523
- MFDS drugMoxamentin Duo Syr.2012-10-22Drug · Prescription · Notification201207318
- MFDS drugJW Levofloxacin Inj.2012-04-19Drug · Prescription · Notification201203044
- MFDS drugNa.K Inj. 2002012-02-23Drug · Prescription · Notification201201138
- MFDS drugCombiflex MCT Peri Inj.2008-10-16Drug · Prescription · Notification200810459
- MFDS drugLavosol Inj.2008-05-27Drug · Prescription · Notification200805884
- MFDS drugEveramin Inj.2008-05-21Drug · Prescription · Notification200805674
- MFDS drugDoctoramin Inj.2008-05-19Drug · Prescription · Notification200805596
- MFDS drugCombiflex Lipid Central Inj.2008-03-14Drug · Prescription · Notification200802850
- MFDS drug10% Dextrose & Sodium.Potassium Inj. 12007-09-18Drug · Prescription · Notification200710602
- MFDS drug10% Dextrose & Sodium.Potassium Inj. 22007-09-18Drug · Prescription · Notification200710603
- MFDS drug0.9% NaCl.K 40 Inj.2007-09-18Drug · Prescription · Notification200710605
- MFDS drugPlaju OP Inj.2006-11-08Drug · Prescription · Notification200606562
- MFDS drugCombiflex Lipid Peri Inj.2006-04-05Drug · Prescription · Notification200601057
- MFDS drugCombiflex Lipid Inj.Revoked2006-04-05Drug · Prescription · Notification200601056
- MFDS drugLipision 10% Inj.2006-04-05Drug · Prescription · Notification200601052
- MFDS drugLipision 20% Inj.2006-04-05Drug · Prescription · Notification200601053
- MFDS drugChoong Wae Normal Saline Inj.2006-02-23Drug · Prescription · Notification200601050
- MFDS drugChoong Wae Hemo B-2 Sol.2006-02-23Drug · Prescription · Approval200601051
- MFDS drugDoctoramin Gold Inj.2004-12-30Drug · Prescription · Notification200400214
- MFDS drugJW Life Ciprofloxacin Injection2002-03-02Drug · Prescription · Notification200200238
- MFDS drugYouvasol Injection1997-09-26Drug · Prescription · Notification199700387
- MFDS drugJ-Hepamin Inj.1997-02-05Drug · Prescription · Notification199700383
- MFDS drugNewtamin Inj.1996-08-29Drug · Prescription · Notification199600268
- MFDS drugBoin ACDA Soln.1996-05-09Drug · Prescription · Notification199603382
- MFDS drugEvasol Injection1977-02-26Drug · Prescription · Notification197700052
Clinical trials
data.go.kr2 MFDS clinical trial authorisations · 2021 (Phase 3 2)
- Phase 3위너프에이플러스페리주2021-05-27
6 trial sites
- Phase 3위너프에이플러스주2021-05-27
7 trial sites
R&D and key agreements
Source: DART corporate disclosureHP연구센터 수액기술 연구개발 · Proprietary Non-PVC material development and R&D in high-quality pharmaceuticals and plant engineering
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition